Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Three strengths of valproic acid among new August price concessions

The Department of Health and Social Care and the National Assembly for Wales have agreed on concessionary prices for the following 16 items for August 2020 prescriptions.

An initial nine price concessions were announced for the month on August 19. A further 16 items were added to the list last week (August 21).

Drug
Strength
Form
Price
Alendronic acid
10mg
tablets (28)
£5.75
Clonidine
25 microgram
tablets (112)
£16.11
Entacapone
200mg
tablets (30)
£10.33
Erythromycin
250mg
gastro-resistant tablets (28)
£4.11
Esomeprazole
40mg
gastro-resistant capsules (28)
£4.59
Hydroxyzine
10mg
tablets (84)
£1.75
Moxonidine
300 microgram
tablets (28)
£8.74
Nizatidine
150mg
capsules (30)
£7.47
Olanzapine
10mg
tablets (28)
£4.23
Prednisolone
20mg
tablets (30)
£7.19
Rasagiline
1mg
tablets (28)
£20.41
Tacrolimus
0.1%
ointment (30)
£24.95
Tacrolimus
0.1%
ointment (60)
£46.64
Valproic acid
150mg
gastro-resistant capsules (100)
£11.37
Valproic acid
300mg
gastro-resistant capsules (100)
£22.77
Valproic acid
500mg
gastro-resistant capsules (100)
£30

Do these reflect the prices you paid in August?

Related Content

Topics


         
Pharmacist
Bermuda
£85,500 per annum

Apply Now
UsernamePublicRestriction

Register

CD006695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel